Observational studyBMC nephrology2025
Associations between intercurrent events and cardiorenal clinical outcomes in non-diabetic chronic kidney disease: a real-world retrospective cohort study in the United States.
Observational study in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic kidney disease (CKD) is a global public health concern, with 50-70% of the burden attributed to non-diabetic aetiology. To expand CKD research, there is a need to identify novel surrogate endpoints preceding cardiorenal outcomes that are commonly used in CKD trials. This study explored and quantified associations between intercurrent events and clinical outcomes in patients with non-diabetic CKD to inform potential surrogate endpoints.
methodsIn this retrospective observational cohort study, adults with non-diabetic, moderate-to-severe CKD (stage 3/4) were identified in the US Optum Clinformatics
resultsThe study cohort included 504,924 patients. An outpatient heart failure diagnosis code was associated with an increased risk of consequent hospitalization for heart failure (hazard ratio [HR]: 12.92, 95% confidence interval [CI]: 12.67-13.17). CKD stage 4 diagnosis code was associated with an increased risk of kidney failure/need for dialysis (HR: 3.75, 95% CI: 3.69-3.81). Dispensation of potassium-removing resins and potassium-binding agents as an intercurrent event was associated with an increased risk of consequent worsening of CKD stage (HR: 4.83, 95% CI: 4.51-5.17). The estimated glomerular filtration rate decline in 295,174 patients with available laboratory data was associated with progressively increased risk of hospitalization for heart failure and kidney failure/need for dialysis.
conclusionsAssociations between intercurrent events and clinical outcomes in patients with non-diabetic CKD were investigated, quantified, and ranked using a large set of routinely collected data from a US claims database. Our approach may help identify novel surrogate endpoints that occur earlier in the disease course and could be leveraged as indicators of clinical outcomes in CKD research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.